Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in Diabetic Nephropathy
NCT00638131Phase 3Terminated
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Jan 2009
- Primary completion
- Mar 2010
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bosentan in diabetic nephropathy (DN), sponsored by Centre hospitalier de l’Université de Montréal. Started Jan 2009; status: terminated.
02
Drugs
bosentan
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00638131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638131.